Centre for Drug Candidate Optimisation (CDCO)

Centre for Drug Candidate Optimisation

The Centre for Drug Candidate Optimisation (CDCO) is a collaborative research centre that provides expertise and infrastructure in ADME lead optimisation to multidisciplinary drug discovery teams for improved compound design, selection and progression​.

Our team is comprised of experienced staff with expertise spanning areas including physicochemical profiling, drug metabolism, in vitro biopharmaceutics, in vivo pharmacokinetics and bioanalysis using LC-MS/MS. We utilise fully validated scientific platforms to provide decision quality data to academic, commercial and not-for-profit drug discovery programs.

QUALITY: As part of the Monash Technology Research Platform Network, we are committed to providing excellence and quality through all stages of research, industry engagement and collaborations. To achieve this objective, we have implemented a platform quality management system that complies with the requirements of ISO 9001:2015 Quality Management System.

Quality thinking, study design and execution are of the highest importance to the CDCO. This principle underpins our approach and involvement in all collaborator programs to support research excellence.

Small Molecule Drug Discovery diagram

The CDCO is part of an integrated capability network of National Research Infrastructure that supports Small Molecule Drug Discovery. These facilities provide expertise and infrastructure to support leading-edge research and boost innovation across Australia. For more information, visit Therapeutic Innovation Australia's Pipeline Navigator for an interactive map of translational capabilities accessible to researchers.